Users Online: 1102
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

MYELOID LEUKEMIA: ORIGINAL ARTICLE

Role of low dose cytarabine in elderly patients with acute myeloid leukemia: An experience

Bashir Yasir, Geelani Sajjad, Bashir Nusrat, Mir Shabeer A, Mushtaq Mosin, Jan M Aleem, Rasool Javid

Year : 2015| Volume: 4| Issue : 1 | Page no: 4-6

   This article has been cited by
 
1 Chemotherapeutic resistance: a nano-mechanical point of view
Collins Otieno Nyongesa,Soyeun Park
Biological Chemistry. 2018; 0(0)
[Pubmed]  [Google Scholar] [DOI]
2 Characteristics and outcomes of older patients with secondary acute myeloid leukemia according to treatment approach
Prajwal Chaitanya Boddu,Hagop M. Kantarjian,Farhad Ravandi,Guillermo Garcia-Manero,Srdan Verstovsek,Elias J. Jabbour,Koichi Takahashi,Kapil Bhalla,Marina Konopleva,Courtney D. DiNardo,Maro Ohanian,Naveen Pemmaraju,Nitin Jain,Sherry Pierce,William G. Wierda,Jorge E. Cortes,Tapan M. Kadia
Cancer. 2017;
[Pubmed]  [Google Scholar] [DOI]
3 Decitabine Compared with Low-Dose Cytarabine for the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia: A Pilot Study of Safety, Efficacy, and Cost-Effectiveness
Linu A. Jacob,S. Aparna,K. C. Lakshmaiah,D. Lokanatha,Govind Babu,Suresh Babu,Sandhya Appachu
Advances in Hematology. 2015; 2015: 1
[Pubmed]  [Google Scholar] [DOI]

 

Read this article